These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16412019

  • 1. The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model.
    Caers J, Günthert U, De Raeve H, Van Valckenborgh E, Menu E, Van Riet I, Van Camp B, Vanderkerken K.
    Br J Haematol; 2006 Feb; 132(4):469-77. PubMed ID: 16412019
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells.
    Marroquin CE, Downey L, Guo H, Kuo PC.
    Immunol Lett; 2004 Aug 15; 95(1):109-12. PubMed ID: 15325806
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V, Wei H, Ego-Osuala D, Chellaiah MA.
    Exp Cell Res; 2006 Jul 15; 312(12):2214-30. PubMed ID: 16631740
    [Abstract] [Full Text] [Related]

  • 10. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.
    Menu E, Asosingh K, Indraccolo S, De Raeve H, Van Riet I, Van Valckenborgh E, Vande Broek I, Fujii N, Tamamura H, Van Camp B, Vanderkerken K.
    Haematologica; 2006 May 15; 91(5):605-12. PubMed ID: 16627256
    [Abstract] [Full Text] [Related]

  • 11. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
    Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J.
    J Bone Miner Res; 2002 Aug 15; 17(8):1486-97. PubMed ID: 12162503
    [Abstract] [Full Text] [Related]

  • 12. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.
    Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T.
    Cancer Res; 1999 Jan 01; 59(1):219-26. PubMed ID: 9892210
    [Abstract] [Full Text] [Related]

  • 13. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.
    Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J.
    J Cell Physiol; 2000 Jul 01; 184(1):118-30. PubMed ID: 10825241
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
    Furger KA, Allan AL, Wilson SM, Hota C, Vantyghem SA, Postenka CO, Al-Katib W, Chambers AF, Tuck AB.
    Mol Cancer Res; 2003 Sep 01; 1(11):810-9. PubMed ID: 14517343
    [Abstract] [Full Text] [Related]

  • 17. Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma.
    Weismann D, Briese J, Niemann J, Grüneberger M, Adam P, Hahner S, Johanssen S, Liu W, Ezzat S, Saeger W, Bamberger AM, Fassnacht M, Schulte HM, Asa SL, Allolio B, Bamberger CM.
    J Pathol; 2009 Jun 01; 218(2):232-40. PubMed ID: 19326399
    [Abstract] [Full Text] [Related]

  • 18. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells.
    Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S.
    Eur J Immunol; 2008 Feb 01; 38(2):489-99. PubMed ID: 18200503
    [Abstract] [Full Text] [Related]

  • 19. Role of osteopontin in adhesion, migration, cell survival and bone remodeling.
    Standal T, Borset M, Sundan A.
    Exp Oncol; 2004 Sep 01; 26(3):179-84. PubMed ID: 15494684
    [Abstract] [Full Text] [Related]

  • 20. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
    Chang PL, Chambers AF.
    J Cell Biochem; 2000 Apr 01; 78(1):8-23. PubMed ID: 10797562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.